CEOInterviews.AI
Start App
Get an email when Robert Langer gives a new interview
One email per new interview. Unsubscribe in one click.
Robert Langer
Institute Professor, MIT

2026 Welch Award - Dr. Robert S. Langer

📅 Oct 29, 2026 The Welch Foundation 11 MIN 164 VIEWS 34 SEGMENTS · 2 SPEAKERS
The Welch Foundation has awarded the 2026 Welch Award in Chemistry to Robert S. Langer. Dr. Langer is honored for pioneering discoveries at the intersection of chemistry and medicine that led to understanding how to control the release of therapeutic macromolecules through materials and how to create new tissues and organs. Professor Langer earned his bachelor’s degree from Cornell University in 1970 and his Sc.D. from MIT in 1974; both degrees are in chemical engineering. Rather than accept an industry position engineering incremental increases in chemical yields, Professor Langer instead fo...

What Robert Langer said

Written from the verified transcript and checked against it. Every figure links to the moment it was said.

Robert Langer, Institute Professor at MIT, discussed his career in biomedical engineering, from early chemistry sets to pioneering drug delivery and tissue engineering. He described his initial rejections from 40 schools and hospitals before joining Judah Folkman at Boston Children's Hospital, where he developed microparticles to deliver large molecules, overcoming skepticism. Langer detailed his patent struggles, including five years of rejections, resolved by citing a 1979 review article. He highlighted the lab's growth and the model of starting companies to commercialize research. Looking ahead, he predicted microneedle patches, long-lasting pills, oral delivery of insulin or mRNA, and drugs crossing the blood-brain barrier for Alzheimer's. He credited the Welch Award for recognizing the field, not just his individual work.

Key takeaways

  1. Langer wrote to 40 schools and hospitals after MIT and none hired him, before joining Judah Folkman at Boston Children's Hospital.
  2. Langer's patent on microparticles was rejected five years in a row, until he used a 1979 review article to convince the examiner.
  3. Langer predicted future drug delivery will include microneedle patches, pills lasting months or a year, and oral insulin or mRNA.
  4. Langer said he found hundreds of ways to make blood vessel inhibitors not work, but one method did, making all the difference.
  5. Langer credited the Welch Award for recognizing the field of drug delivery, not just his own contributions.

Numbers and commitments

FigureWhat it refers toTypeAt
40 Schools and hospitals that rejected Langer's applications metric 2:35
1979 Year of the review article that helped secure the patent timeline 8:22
1974 Year when almost no one was doing this work timeline 11:07
50 years Duration of Langer's work in this field timeline 10:00

Chapters

  1. 0:00Early interest in chemistry
  2. 2:35Career path and rejections
  3. 3:08Working with Judah Folkman
  4. 3:34Developing microparticles
  5. 7:44Patent struggle and resolution
  6. 8:47Starting companies
  7. 10:00Future of drug delivery

Questions asked in this interview

2
  1. 10:29You know, how many fields has he created?
  2. 10:53It's easy to look at Bob's citations, right?
Robert Langer 0:14 ↗
When I was a little boy, there was a company called Gilbert and they made chemistry sets, microscope sets, erector sets. I used to have a little lab in our basement. You know, I'd mix different chemicals and I always liked magic, so I liked making colors change, making up polymers, making sort of rubbery things. So it was fun.
Well, my name's Bob Langer. I'm Institute Professor at MIT and I teach and I do research on biomedical engineering, but applying chemistry to create new materials to come up with new treatments for different diseases.
Co-Panelist 0:51 ↗
I think there are multiple classics that Bob's written. It starts with his papers in the late 1970s envisioning how to deliver large molecules, his ideas with regard to angiogenesis, using messenger RNA as delivery vehicles. I mean, I think there are so many things that Bob is responsible for.
Bob defined drug delivery, tissue engineering and biomaterials so broadly. Prior to him, people didn't even think it was possible. People didn't even think they were important.
I think the key aspect of his work is he took this engineering approach to looking at and solving medical problems. There are all these great drugs that had all this potential, but they're really hard to deliver or they have short half-lives. And so he was able to really formulate these things using polymers, which at the time really was just so foreign.
Actually, a lot of early cell-based therapies, yeah, came out of technologies from the Langer Lab. So initially this was called tissue engineering, cell engineering.
I think Bob is a pioneer in two main areas: drug delivery and tissue engineering. In drug delivery, really it used to be that we made medical devices out of existing materials. Since Bob was a chemical engineer, he was able to make new materials from scratch. So that sort of idea that you didn't have to be stuck with what existed was, I think, really the sort of ground-breaking insight.
Robert Langer 2:35 ↗
After I graduated from MIT, I was looking for something where I guess I felt I could help people, either by health-related things or education. I wrote to 40 schools in chemistry education, as I liked that. None of them would hire me. I mean, they didn't even write me back. Same thing with medical things. I'd write to hospitals and medical schools. They didn't write back either. And somebody when I was in the lab said, 'There's a surgeon at Boston Children's Hospital named Judah Folkman. He says sometimes he hires unusual people.'
Dr. Folkman, I mean, he was really amazing. I mean, I think he to this day was the youngest full professor at Harvard Medical School. And he was a visionary. He basically had this idea: if you could stop blood vessels, you could stop cancer. And he further thought that that was chemically mediated. And pretty much everybody in the medical community didn't agree with that.
So our idea is we'd put a certain type of tumor in these sites, which would cause blood vessels to grow. But then we needed a tiny, like, microparticle or nanoparticle that you could put right next to it to see if it would stop them. If we were going to solve the blood vessel problem, we had to solve the delivery problem. So I spent a lot of time, I mean, you know, experimenting with different materials, different designs, different techniques. And I found hundreds of ways to get it to not work, but one that did. And that made all the difference.
So the Science paper was showing that blood vessel inhibitors existed and providing assays for it. And the Nature paper was for the first time you could deliver large molecules, including nucleic acids, for, you know, any period of time. But there was a lot of skepticism about this field then.
Co-Panelist 4:22 ↗
I would say the lack of belief in it went well beyond that year.
Conventional wisdom was that you could not deliver large molecules like proteins or growth factors from any of these materials. And what Bob figured out was that if you made them sponge-like and the pores were connected in a certain way, that you could in fact implant things and deliver these big, what we call macromolecules, into the body.
Everything that he's done are things that people have said not possible, you can't, and it's impossible to even think of doing it. Bob always says, 'Why not?'
All the reasons people said why this will not work: you cannot deliver proteins through these polymers. And of course, he showed that it could work. Not only that, but it works better and it can really improve the efficacy of my patient outcomes.
Robert Langer 5:22 ↗
Now we had a whole new toolkit of making materials to do what you wanted, and a new capability, which was to deliver biological molecules. And so then I think he and all of us sort of imagined, like, what could you do with that? You could get tissues to grow, you could deliver RNA.
Co-Panelist 5:41 ↗
You were thinking of radically different ideas, and you had people with diverse backgrounds. There were engineers, there were doctors, there were scientists.

7 more exchanges in this transcript

Sign in free to read the rest of this interview. No card required.

Sign in to read the full transcript

Cite this transcript

APA, MLA, BibTeX
APA

Langer, R. (2026, October 29). 2026 Welch Award - Dr. Robert S. Langer [Interview transcript]. The Welch Foundation. CEOInterviews.AI. https://ceointerviews.ai/interview/3211949/

MLA

Robert Langer. "2026 Welch Award - Dr. Robert S. Langer." The Welch Foundation, 29 Oct. 2026. Transcript, CEOInterviews.AI, https://ceointerviews.ai/interview/3211949/.

BibTeX
@misc{langer2026_3211949,
  author       = {Robert Langer},
  title        = {2026 Welch Award - Dr. Robert S. Langer},
  howpublished = {Interview transcript, The Welch Foundation. CEOInterviews.AI},
  year         = {2026},
  month        = {oct},
  url          = {https://ceointerviews.ai/interview/3211949/},
  note         = {Speaker-attributed transcript with timestamps}
}